《大行報告》匯豐研究升新奧能源(02688.HK)目標價至75元 業績符預期
匯豐研究發表報告指,新奧能源(02688.HK)去年純利按年增16%至68億元人民幣,符預期。扣除一次性收益和液化天然氣(LNG)貿易收益後,該行估算其去年核心利潤為61億元人民幣,按年增8%。關鍵營運指標(如銷氣量及接駁量)均基本符合其最新指引。全年度總股息升至每股2.95元,按年升1%,意味以核心每股純利計派息比率50%,低於對上一年的52%。
該行相信,業績符合預期將會持續重建公司的業績紀錄和投資者的信心,從而實現價值恢復。該行維持其「買入」評級,目標價由74元輕微上調至75元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.